BioCentury | Jul 21, 2011
Distillery Therapeutics

Indication: Musculoskeletal disease

...include evaluating ABP1 via other delivery routes and in additional animal models of muscular dystrophy. Valentia Biopharma S.L....
...future research. SciBX 4(28); doi:10.1038/scibx.2011.800 Published online July 21, 2011 Patent application filed; licensed to Valentia Biopharma...
Items per page:
1 - 1 of 1
BioCentury | Jul 21, 2011
Distillery Therapeutics

Indication: Musculoskeletal disease

...include evaluating ABP1 via other delivery routes and in additional animal models of muscular dystrophy. Valentia Biopharma S.L....
...future research. SciBX 4(28); doi:10.1038/scibx.2011.800 Published online July 21, 2011 Patent application filed; licensed to Valentia Biopharma...
Items per page:
1 - 1 of 1